Management and follow-up of localized Wegener's granulomatosis: A review of five cases

Acta Oto-Laryngologica

Volumn 124, Issue 9, 2004, Pages 1103-1108

  Nishiike, Suetaka ^a   Kato, Takashi ^a   Nagai, Miki ^a   Konishi, Masaki ^a   Sakata, Yoshiharu ^a  

^a Suita Municipal Hospital   (Japan)

Author keywords

Cytoplasmic anti neutrophil cytoplasmic antibodies; Dacryocystorhinostomy; Methotrexate; Pachymeningitis; Rhinoplasty; Trimethoprim sulfamethoxazole; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DACRYOCYSTORHINOSTOMY; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; NOSE RECONSTRUCTION; PRIORITY JOURNAL; RELAPSE; SYSTEMIC DISEASE; TISSUE DISTRIBUTION; TUMOR LOCALIZATION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; RECURRENCE; WEGENER GRANULOMATOSIS;

EID: 8744250288     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410020310     Document Type: Article

References (24)

1. Nikolaou AC, Valchtsis KC, Daniilidis MA, Petridis DG, Daniilidis IC. Wegener's granulomatosis presenting with bilateral facial palsy. Eur Arch Otorhinolaryngol 2001; 258: 198-202.
2. Takagi D, Nakamura Y, Maguchi S, Furuta Y, Fukuda S. Otologic manifestations of Wegener's granulomatosis. Laryngoscope 2002; 112: 1684-90.
3. Fenton JE, O'Sullivan TJ. The otological manifestations of Wegener's granulomatosis. J Laryngol Otol 1994; 108: 144-6.
4. Moussa AEM, Abou-Elhmad KA. Wegener's granulomatosis presenting as mastoiditis. Ann Otol Rhinol Laryngol 1998; 107: 560-3.
5. Congdon D, Sherris DA, Specks U, McDonald T. Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis. Laryngoscope 2002; 112: 731-7.
6. Ahmad I, Lee WC, Nagendran V, Wilson F, Shortridge RTJ. Localized Wegener's granulomatosis in otolaryngology: a review of six cases. ORL J Otorhinolaryngol Relat Spec 2000; 62: 149-55.
7. McDonald TJ, DeRemee RA. Head and neck involvement in Wegener's granulomatosis. In: Gross WL, ed. ANCA-associated vasculitides; immunological and clinical aspects. New York: Plenum Press; 1993. p. 309-13.
8. Langford CA, Sneller MC. Update on the diagnosis and treatment of Wegener's granulomatosis. Adv Intern Med 2001; 46: 177-206.
9. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; i: 425-9.
10. Variainen E, Nuutinen J. Head and neck manifestations of Wegener's granulomatosis. Ear Nose Throat J 1992; 71: 423-8.
11. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-71.
12. Ohashi H, Itoh M, Ogawa N, Sudo Y, Endo S, Okugawa T, et al. Wegener's granulomatosis in a patient with rheumatoid arthritis. Intern Med 1992; 31: 1128-31.
13. Chinoy H, McKenna F. Wegener's granulomatosis and rheumatoid arthritis overlap. Rheumatology 2002; 41: 588-9.
14. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
15. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology 2001; 40: 492-8.
16. Wegener F. Wegener's granulomatosis. Eur Arch Otorhinolaryngol 1990; 247: 133-42.
17. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-94.
18. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. Analysis of 42 Wegener's granulomatosis patients treated with methotrexate and prednisolone. Arthritis Rheum 1995; 38: 608-13.
19. Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999; 42: 2666-73.
20. Reinhold-Kellar E, Fink COE, Herlyn K, Gross WL, de Groot KD. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002; 47: 326-32.
21. Israel H. Sufamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988; 148: 2293-5.
22. Valeriano-Marcet J, Spiera H. Treatment of Wegener's granulomatosis with sufamethoxazole-trimethoprim. Arch Intern Med 1991; 151: 1649-52.
23. Bullen CL, Liesgang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983; 90: 279-90.
24. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener's granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001; 13: 3-11.